Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Stock Dropped to Hold by Berenberg Bank

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) was downgraded by research analysts at Berenberg Bank from a “buy” rating to a “hold” rating in a research note issued to investors on Tuesday, MarketBeat Ratings reports.

Several other equities research analysts have also commented on the stock. Weiss Ratings reiterated a “hold (c)” rating on shares of Fresenius Medical Care AG & Co. KGaA in a research note on Tuesday, August 4th. Zacks Research upgraded shares of Fresenius Medical Care AG & Co. KGaA from a “strong sell” rating to a “hold” rating in a research note on Monday, July 6th. Citigroup reaffirmed a “neutral” rating on shares of Fresenius Medical Care AG & Co. KGaA in a report on Friday, July 17th. BNP Paribas Exane cut Fresenius Medical Care AG & Co. KGaA from a “neutral” rating to an “underperform” rating and set a $19.90 target price on the stock. in a research report on Tuesday, July 28th. Finally, Truist Financial set a $25.00 target price on Fresenius Medical Care AG & Co. KGaA in a report on Wednesday, August 5th. Seven investment analysts have rated the stock with a Hold rating and five have given a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Reduce” and a consensus target price of $23.67.

Fresenius Medical Care AG & Co. KGaA Stock Up 1.2%

FMS stock opened at $22.95 on Tuesday. The company has a current ratio of 1.07, a quick ratio of 0.75 and a debt-to-equity ratio of 0.43. Fresenius Medical Care AG & Co. KGaA has a twelve month low of $20.02 and a twelve month high of $27.64. The company’s 50 day moving average is $23.46 and its two-hundred day moving average is $22.95. The stock has a market cap of $12.33 billion, a P/E ratio of 11.89, a PEG ratio of 4.21 and a beta of 0.76.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) last issued its quarterly earnings data on Monday, August 3rd. The company reported $0.66 earnings per share for the quarter, topping the consensus estimate of $0.62 by $0.04. Fresenius Medical Care AG & Co. KGaA had a net margin of 4.83% and a return on equity of 9.28%. The business had revenue of $5.55 billion during the quarter, compared to the consensus estimate of $5.48 billion. Research analysts expect that Fresenius Medical Care AG & Co. KGaA will post 2.25 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Fresenius Medical Care AG & Co. KGaA

A number of hedge funds have recently added to or reduced their stakes in the company. Pzena Investment Management LLC lifted its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 2.0% in the first quarter. Pzena Investment Management LLC now owns 15,052,822 shares of the company’s stock valued at $339,592,000 after purchasing an additional 299,986 shares in the last quarter. Royal Bank of Canada increased its stake in shares of Fresenius Medical Care AG & Co. KGaA by 479.2% during the 1st quarter. Royal Bank of Canada now owns 216,861 shares of the company’s stock worth $4,893,000 after purchasing an additional 179,418 shares in the last quarter. Assetmark Inc. raised its position in shares of Fresenius Medical Care AG & Co. KGaA by 190.7% during the 1st quarter. Assetmark Inc. now owns 132,320 shares of the company’s stock worth $2,985,000 after purchasing an additional 86,798 shares during the last quarter. Moran Wealth Management LLC raised its position in shares of Fresenius Medical Care AG & Co. KGaA by 31.5% during the 1st quarter. Moran Wealth Management LLC now owns 347,773 shares of the company’s stock worth $7,846,000 after purchasing an additional 83,311 shares during the last quarter. Finally, Ritholtz Wealth Management raised its position in shares of Fresenius Medical Care AG & Co. KGaA by 252.7% during the 1st quarter. Ritholtz Wealth Management now owns 84,658 shares of the company’s stock worth $1,910,000 after purchasing an additional 60,652 shares during the last quarter. Institutional investors and hedge funds own 8.37% of the company’s stock.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA is a Germany-based health care company focused on kidney disease and dialysis services. The company provides hemodialysis and peritoneal dialysis treatments through a global network of outpatient dialysis clinics and supports patients with related care and medical services.

In addition to operating dialysis centers, Fresenius Medical Care develops and manufactures products used in renal care. Its portfolio includes dialysis machines, dialyzers, bloodlines, concentrates, solutions, pharmaceuticals and other disposable supplies.